Search

everythinglearnresearchcommunity

for

Search:↓

The combination of oral finasteride and dutasteride with topical minoxidil effectively promotes new hair growth in most people, with minimal side effects.

DHT in the human prostate is produced through multiple pathways, not just from testosterone.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Sex steroids produced in the hippocampus are crucial for brain functions like memory and learning in rodents.

Hormones and signaling pathways control sebaceous gland function and could help treat acne.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Nanocarrier technology in cosmetics improves ingredient delivery and effectiveness while reducing side effects.

Dutasteride is more effective than finasteride at increasing hair count and reversing hair thinning in men with hair loss, but both have similar side effects.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

Testosterone may influence COVID-19 severity and outcomes.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Bioengineering can potentially treat hair loss by regenerating hair follicles and cloning hair, but the process is complex and needs more research.

Minoxidil can reduce functions related to androgen receptors.

Neuroactive steroids and the enzyme 5α-reductase might be involved in the development of Tourette's syndrome.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Certain diets may help with hair growth in people with different types of hair loss.